Amniotic fluid cytokine profile in association with fetal hyperechogenic bowel

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 128, Issue 1-2, 2006, Pages 86-90

  Oboh, Alex E ^a   Orsi, Nicolas M ^b   Campbell, James ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cytokines; Fetal hyperechogenic bowel; Inflammation

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FETAL HYPERECHOGENIC BOWEL; FETUS; HUMAN; IMMUNOASSAY; INTESTINE FUNCTION DISORDER; NECROTIZING ENTEROCOLITIS; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; TREATMENT OUTCOME;

EID: 33748190157     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.01.011     Document Type: Article

References (32)

1. Romero R., Gomez R., Galasso M., et al. The natural interleukin-I receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection. Am J Obstet Gynecol 171 (1994) 912-921
2. Chitty L.S., Hunt G.H., Moore J., and Lubb M.O. Effectiveness of routine ultrasound in detecting fetal structural abnormalities in a low risk population. Br Med J 303 (1991) 1165-1169
3. Luck C.A. Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries. Br Med J 304 (1992) 1474-1478
4. Whittle M. Ultrasonographic "soft markers" of fetal chromosomal defects. Br Med J 314 (1973) 918
5. Dickie J.M., and Crane J.P. Sonographically detected hyperechogenic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol 80 (1992) 778-782
6. Carrol S.G., and Maxwell D.J. The significance of echogenic areas in the fetal abdomen. Ultrasound Obstet Gynecol 2 (1996) 293-298
7. Hill L.M., Fries J., Hecker J., and Grzybek P. Second trimester echogenic small bowel: an increase risk for adverse perinatal outcome. Prenatal Diagn 14 (1994) 845-850
8. Fakhry J., Reisner M., Shapiro L.R., Schecther A., Pait L.P., and Glennon A. Increases echogenicity in the lower fetal abdomen: a common normal variant in the second trimester. J Ultrasound Med 5 (1986) 489-492
9. Muller F., Dommergues M., Aubry M.C., et al. Hyperechogenic fetal bowel: an ultrasound marker for adverse fetal and neonatal outcome. Am J Obstet Gynecol 173 (1995) 508-513
10. Tibboel D., Gaillard J.L.J., and Molenaar J.C. The importance of mesenteric vascular insufficiency in meconium peritonitis. Hum Pathol 17 (1986) 411-416
11. Sepulveda W., Reid R., Nicolaides P., Prendiville O., Chapman R., and Fisk N.M. Second trimester echogenic bowel and intraamniotic bleeding: association between fetal bowel echogenicity and amniotic fluid spectrophotometry. Am J Obstet Gynecol 174 (1996) 839-842
12. Peters M.T., Lowe T.W., Capenter A., and Kole S. Prenatal diagnosis of congenital cytomegalovirus infection with abnormal triple-screen results and hyperechogenic fetal bowel. Am J Obstet Gynecol 173 (1995) 953-954
13. Svinarich D.M., Bitonti O.M., Romero R., and Gonik B. Induction and post translational expression of cytokines in a first-trimester trophoblast cell line by lipopolysaccharide. Am J Obstet Gynecol 175 (1996) 970-973
14. Schultz C., Temming P., Bucsky P., Gopel W., Strunk T., and Hartel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol 135 (2004) 130-136
15. Apuzzio J., Chan Y., Al-Khan A., Illsley N., Kim P.L., and Vonhaggen S. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery. J Matern Fetal Neonatal Med 15 (2004) 313-317
16. El-Shazly S., Makhseed M., Azizieh F., and Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am J Reprod Immunol 52 (2004) 45-52
17. Hagberg H., Mallard C., and Jacobsson B. Role of cytokines in preterm labour and brain injury. Br J Obstet Gynaecol 112 (2005) 16-18
18. Wolf H.M., and Eibl M.M. The anti-inflammatory effect of an oral immunoglobulin (IgA-IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis. Acta Paediatr Suppl 396 (1994) 37-40
19. Ispas D. Evidence of TNF system activation and high expression of TNF alpha messenger transcripts in necrotizing enterocolitis of HIV-infected children. Rom J Virol 50 (1999) 53-70
20. Nanthakumar N.N., Young C., Ko J.S., et al. Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288 (2005) G85-G92
21. Powell C., Orsi N.M., Simpson N., and Levene M. Characterisation of the cytokine inflammatory response in LPS stimulated full-term cord blood. J Perinat Med 32 (2004) 440-445
22. Spong C.Y., Scherer D.M., Ghidini A., Pezzullo J.C., Salafia C.M., and Eglinton G.S. Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict small-for-gestational-age infants. Am J Reprod Immunol 37 (1997) 236-239
23. Vesce F., Scapoli C., Giovannini G., et al. Cytokine imbalance in pregnancies with fetal chromosomal abnormalities. Hum Reprod 17 (2002) 803-808
24. Nanthakumar N.N., Young C., Ko J.S., et al. Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288 (2005) G85-G92
25. Nanthakumar N.N., Fusunyan R.D., Sanderson I., and Walker W.A. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 97 (2000) 6043-6048
26. Wenstrom K.D., Andrews W.W., Hauth J.C., Goldenberg R.L., DuBard M.B., and Cliver S.P. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 178 (1998) 546-550
27. Huber A., Diehl W., Zikulnig L., et al. Amniotic fluid and maternal blood characteristics in severe mid-trimester twin-twin transfusion syndrome. Fetal Diagn Ther 19 (2004) 504-509
28. Heikkinen J., Mottonen M., Pulkki K., Lassila O., and Alanen A. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand J Immunol 53 (2001) 310-314
29. Heyborne K.D., McGregor J.A., Henry G., Witkin S.S., and Abrams J.S. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 171 (1994) 55-59
30. Olah K.S., Vince G.S., Neilson J.P., Deniz G., and Johnson P.M. Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J Reprod Immunol 32 (1996) 89-98
31. Goepfert A.R., Andrews W.W., Carlo W., et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol 191 (2004) 1375-1381
32. Romagnoli C., Frezza S., Cingolani A., et al. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 160 (2001) 345-350